12:00 AM
 | 
May 26, 2008
 |  BioCentury  |  Finance

Late-stage opportunities

Late-stage opportunities

Ph II Ph III & registration
Company % chg [12/29/06 to 3/31/08] Company % chg [12/29/06 to 3/31/08]
Phoqus (LSE:PQS) -89% Protalix (AMEX:PLX) (A) -88%
ReGen (LSE:RGT) -71% Amarin (NASDAQ:AMRN; LSE:AMRN) -88%
Karo Bio (SSE:KARO) -68% GPC (NASDAQ:GPC; Xetra:GPC)

Read the full 368 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >